MDQK.HM MediNavi AG (HAM) to €7.50 on 04 Feb 2026: watch volume and moving averages

MediNavi AG’s MDQK.HM stock surged to €7.50 in market hours on 04 Feb 2026, up 200.00% from the previous close. The jump pushed the intraday range from €2.50 to €7.50 and lifted the price well above the 50-day average of €2.50 and the 200-day average of €2.00. Trading volume reached 35 shares versus an average of 41, flagging concentrated interest. We review price action, valuation metrics, sector context, and our model forecast for risk-aware traders.

MDQK.HM stock: intraday price and volume snapshot

MDQK.HM stock closed at €7.50 after opening at €2.50 on HAM in Germany. The day low was €2.50 and the day high was €7.50. Volume was 35 versus an average volume of 41, giving a relative volume of 0.85. The sharp 200.00% change reflects a concentrated block move rather than broad retail flow.

MDQK.HM stock technicals and momentum

Price sits well above the moving averages with a 50-day average of €2.50 and a 200-day average of €2.00. The model’s ATR shows €5.00 intraday volatility. Momentum indicators show limited history and many oscillators return neutral values. Traders should treat the move as high volatility and monitor follow-through above €7.50 for trend confirmation.

MDQK.HM stock fundamentals and valuation

Company metrics show limited public revenue and EPS data, with EPS reported as null and a market cap listed as 0. Key ratios include a current ratio of 41.50 and an enterprise value over EBITDA of 2.17. Return on equity reads approximately -6.60%, reflecting operating losses. The financial snapshot points to asset strength but low operating scale.

MDQK.HM stock sector context and catalysts

MediNavi AG operates in Healthcare information services in Germany. The healthcare sector has returned 1.18% year to date in our sector sample. MDQK.HM’s platform focus on second opinions and doctor discovery could gain from digital health demand. Catalyst risk remains, and any corporate update or partnership would drive further volume.

Meyka grade, model forecast and price targets for MDQK.HM stock

Meyka AI rates MDQK.HM with a score out of 100: the score is 58.59, grade C+, suggestion HOLD. This grade factors S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month base case price of €5.00, implying a downside of -33.33% from the current €7.50. A bull scenario target sits at €12.00, implying upside of +60.00%. Forecasts are model-based projections and not guarantees.

MDQK.HM stock risks and trading checklist

Major risks include very low liquidity, limited public financials, and uneven volume. Shares outstanding and EPS are not disclosed, increasing execution risk. For traders, set strict stop limits, size positions for low liquidity, and confirm catalysts before buying. Use the Meyka stock page for live quotes and alerts.

Final Thoughts

MDQK.HM stock posted a strong intraday move to €7.50 on 04 Feb 2026 during market hours on HAM in Germany. The 200.00% spike lifted price far above the 50-day and 200-day averages, but volume remained low at 35 shares, which raises liquidity and execution concerns. Fundamental ratios show a current ratio of 41.50 and an enterprise value over EBITDA of 2.17, while EPS data remain unavailable. Meyka AI rates MDQK.HM 58.59/100 (C+, HOLD) and models a base case target of €5.00, implying -33.33% downside from the current price. Traders focusing on high-volume movers should watch for confirmatory volume above €7.50 or clear corporate news. For details and live updates visit the company site source and our live quote page at Meyka stock page. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.